Sentences with phrase «centered on cancer patients»

Last week, jurors heard about another alleged quid pro quo scheme centered on cancer patients being referred by Silver to the Weitz & Luxenberg personal injury law firm.

Not exact matches

It will focus its initial clinical sequencing efforts on cancer, teaming up with the Moores Cancer Center at the University of California, San Diego to sequence the genomes of every patient who is treated there, as well as perform a full genome sequence on their tcancer, teaming up with the Moores Cancer Center at the University of California, San Diego to sequence the genomes of every patient who is treated there, as well as perform a full genome sequence on their tCancer Center at the University of California, San Diego to sequence the genomes of every patient who is treated there, as well as perform a full genome sequence on their tumors.

It can be everything from an über - helpful call - center rep to an oncology adviser, recommending cancer treatments on the basis of a patient's genetic profile and thousands of clinical trials and medical journal articles it has analyzed.

Future resources from the NCI Center for Cancer Genomics (CCG), which oversees TCGA and other activities, will support more translationally focused research, including databases with genomic information on clinical samples linked to outcomes of their patient donors.

«Although FDA approval is critically important for introducing a new screening test or algorithm, providers ultimately rely on guidance or guidelines to help them make the best decisions for their patients and want to understand advantages, disadvantages and unknowns associated with a new screening approach,» said Huh, who is a senior scientist for the UAB Comprehensive Cancer Center, Director of the UAB Division of Gynecologic Oncology, and is also a board member for both the American Society for Colposcopy and Cervical Pathology and the Society of Gynecologic Oncology.

The Czech - born psychiatrist conducted dozens of government - sanctioned LSD experiments in the»50s,»60s, and early»70s on heroin addicts, alcoholics, and terminal cancer patients in his native Prague and later at the Maryland Psychiatric Research Center, a mental health facility in Catonsville, Maryland, where he was chief of psychiatric research.

Research teams focused on both cutaneous and uveal melanoma are fast - tracking discoveries into the clinical setting, and bringing novel therapeutic options to patients in the Philadelphia region,» said Karen Knudsen, Director of the Sidney Kimmel Cancer Center.

«The PSA test is based on the fact that men with higher levels of the PSA protein are more likely to have prostate cancer,» said William Catalona, MD, principal investigator on the Prostate Health Index clinical study and urologist at Northwestern Medicine and director of the Clinical Prostate Cancer Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, where they began using the phi test on patients in Febcancer,» said William Catalona, MD, principal investigator on the Prostate Health Index clinical study and urologist at Northwestern Medicine and director of the Clinical Prostate Cancer Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, where they began using the phi test on patients in FebCancer Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, where they began using the phi test on patients in FebCancer Center of Northwestern University, where they began using the phi test on patients in February.

During recent trials at the Moffit Cancer Center in Tampa, Florida, the treatment successfully removed a tumour on a patient's nose.

In the first study to report on the association of aspirin use with breast cancer outcomes in a large patient population, researchers examined the pattern of aspirin use, cancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cacancer outcomes in a large patient population, researchers examined the pattern of aspirin use, cancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cacancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative caCancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cancers.

«Oncologists here at Moores Cancer Center at UC San Diego Health and elsewhere can often personalize cancer therapy based on an individual patient's unique cancer mutations,» said senior author Trey Ideker, PhD, professor of genetics at UC San Diego School of MedCancer Center at UC San Diego Health and elsewhere can often personalize cancer therapy based on an individual patient's unique cancer mutations,» said senior author Trey Ideker, PhD, professor of genetics at UC San Diego School of Medcancer therapy based on an individual patient's unique cancer mutations,» said senior author Trey Ideker, PhD, professor of genetics at UC San Diego School of Medcancer mutations,» said senior author Trey Ideker, PhD, professor of genetics at UC San Diego School of Medicine.

Networks or not, doctors and health officials also have to decide how to treat patients based on published research that could be overturned, notes oncologist Benjamin Djulbegovic of the H. Lee Moffitt Cancer Center and Research Institute in Tampa.

«Other studies have looked at racial disparities in treatment and still others have focused on racial differences in survival rates of cancer patients, but our research attempted to go further by demonstrating the impact of race - based inequalities in cancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer patients, but our research attempted to go further by demonstrating the impact of race - based inequalities in cancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer CCancer Center.

«If the risk score is very high, you might decide, after discussion with the patient, on a less aggressive approach,» says oncologist William Tew of Memorial Sloan Kettering Cancer Center in New York City.

If so, says Grover Bagby, a hematologist who directs the Oregon Cancer Center at the Oregon Health Sciences University in Portland, further work to decipher the protein's exact function could shed light on how to treat a much larger population of patients with leukemia, certain other forms of cancer, and aplastic aCancer Center at the Oregon Health Sciences University in Portland, further work to decipher the protein's exact function could shed light on how to treat a much larger population of patients with leukemia, certain other forms of cancer, and aplastic acancer, and aplastic anemia.

Mapping these sorts of connections could make it possible to optimize which drugs patients get based on their tumor genetics,» said Bandyopadhyay, a member of the UCSF Helen Diller Family Comprehensive Cancer Center and the Quantitative Biosciences Institute.

Screening for colorectal cancer based on age alone may contribute to both underuse and overuse of the tests among older patients, according to a study by investigators at the University of Michigan and the Veterans Affairs Center for Clinical Management Research.

«It's incredibly encouraging to find possible new options for patients with an aggressive cancer like triple negative breast cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of thcancer like triple negative breast cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of thcancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of thCancer Center, and former CEO of the ICR.

How an oncologist bases his or her treatment decision can be based on experience, comfort level prescribing and the patient's health,» said senior author Paul Fanta, MD, assistant clinical professor of medicine and oncologist at UC San Diego Moores Cancer Center.

One report, focusing on clinical trial patients with advanced kidney cancer treated with checkpoint inhibitors, is from scientists at Dana - Farber Cancer Institute and the Broad Institute of MIT and Harvard, led by Eliezer Van Allen, MD, of Dana - Farber and the Broad, and Toni Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana - Fcancer treated with checkpoint inhibitors, is from scientists at Dana - Farber Cancer Institute and the Broad Institute of MIT and Harvard, led by Eliezer Van Allen, MD, of Dana - Farber and the Broad, and Toni Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana - FCancer Institute and the Broad Institute of MIT and Harvard, led by Eliezer Van Allen, MD, of Dana - Farber and the Broad, and Toni Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana - Farber.

«Most clinicians have felt that «more was better» when it came to blocking testosterone in prostate cancer patients, however, results for the specific endpoints we focused on, OS and DSS, indicate that this was clearly not the case,» said Amin Mirhadi, MD, lead author of the study and a radiation oncologist at Cedars - Sinai Medical Center in Los Angeles.

«This is really an important finding, because before patients and their doctors decide to pursue active surveillance as a management option for prostate cancer, both the physician and patient should agree on a follow - up schedule to closely monitor the cancer,» said Chamie, who is surgical director of UCLA's bladder cancer program and a member of the Jonsson Comprehensive Cancer Ccancer, both the physician and patient should agree on a follow - up schedule to closely monitor the cancer,» said Chamie, who is surgical director of UCLA's bladder cancer program and a member of the Jonsson Comprehensive Cancer Ccancer,» said Chamie, who is surgical director of UCLA's bladder cancer program and a member of the Jonsson Comprehensive Cancer Ccancer program and a member of the Jonsson Comprehensive Cancer CCancer Center.

The report contains data on 3,727 patients whose samples were analyzed during the first year of the Profile program at Dana - Farber / Brigham and Women's Cancer Center and Boston Children's Hospital.

«With continued adoption of SBRT in community cancer centers, it is our hope that more patients will receive curative SBRT and the number of patients left untreated based on age or medical comorbidity will continue to fall.»

«Low levels of functional BRCA are associated with a greater number of clonal mutations and enhanced immune recruitment, which may explain the greater chemosensitivity of these tumors and better outcomes for patients,» explained Christos Hatzis, assistant professor of medicine and director of Breast Bioinformatics, Yale Cancer Center and senior author on the paper.

This may be because, at the referral center studied, there is a dedicated program that provides support and counselling, focusing mostly on breast cancer patients within the first year of cancer diagnosis.

«What we see is an association between shorter periods of progression - free survival and overall survival in patients whose blood has higher levels of hypermethylated DNA, and we can see this very early on, after just four weeks of treatment,» says Sara Sukumar, Ph.D., professor of oncology at the Johns Hopkins University School of Medicine and member of the Kimmel Cancer Center, who developed the test with Johns Hopkins scientist Mary Jo Fackler, Ph.D., and others.

Thrive magazine is an award - winning quarterly publication of the U-M Comprehensive Cancer Center, offering inspirational patient stories, news and information on programs and services, tips on coping and living with cancer andCancer Center, offering inspirational patient stories, news and information on programs and services, tips on coping and living with cancer andcancer and more.

We shall be the premier cancer center in the world, based on the excellence of our people, our research - driven patient care and our science.

Of the 22 patients whose tumors successfully grafted, six died before data from the mice were available, but in 13 of the remaining 16 cases, there was a positive correlation between mouse and human results.2 In a second study, performed in collaboration with Manuel Hidalgo of the Spanish National Cancer Research Center, the team found that 6 of 13 patients with advanced solid tumors who were treated based on results from personalized PDX mice had partial tumor remissions, even in cases where genetic sequencing of the tumor showed no actionable mutations.3

Hungerford, a predoctoral fellow, was writing his doctoral thesis on chromosomes in a genetics lab at Fox Chase Cancer Center, and detected a tiny flaw in chromosomes from the blood cells of patients with a type of leukemia.

On Monday, Oct. 13, at 4 p.m., in honor of the first ever «Metastatic Breast Cancer Awareness Day,» the University of Chicago Medical Center will present a free public forum in the atrium of the Duchossois Center for Advanced Medicine, 5758 S. Maryland Ave. Gov. Rod Blagojevich signed a proclamation for the day in honor of metastatic breast cancer patients, and 2008 is the first year it will be obsCancer Awareness Day,» the University of Chicago Medical Center will present a free public forum in the atrium of the Duchossois Center for Advanced Medicine, 5758 S. Maryland Ave. Gov. Rod Blagojevich signed a proclamation for the day in honor of metastatic breast cancer patients, and 2008 is the first year it will be obscancer patients, and 2008 is the first year it will be observed.

About MD Anderson The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and preveCancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevecancer patient care, research, education and prevention.

The vice president said that in recent months he has visited a dozen cancer centers to meet with cancer experts and patients, and talked to several foreign leaders who want to work with the United States on the cancer effort.

In the new study published in JAMA Oncology on June 4, Saad Khan, from the University of Texas Southwestern Medical Center, and colleagues said that a chunk of lung cancer patients with autoimmune disease are not eligible to receive the latest immunotherapy treatments.

Based on our findings, the occurrence of cancer is much higher in adults over 75 years of age compared with the proportion of patients in this age group who enroll in clinical trials,» said lead study author Bindu Kanapuru, MD, medical officer in the Division of Hematology Products, Office of Hematology and Oncology Products in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, who presented the results at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9 — 12 in Atlanta.

she asked a packed room of researchers, patients, survivors and patient advocates at Fred Hutchinson Cancer Research Center on Monday.

We are keenly dependent on biostatisticians for ensuring that our clinical trials yield useful information for future generations of patients,» says Maitra, who is the scientific director for the Sheikh Ahmed Pancreatic Cancer Research Center.

As a physician in the Comprehensive Cancer Risk and Prevention Clinic and the Celiac Center, she is particularly focused on diagnosing and treating patients with genetic disorders such as hereditary gastrointestinal cancer syndromes and celiac diCancer Risk and Prevention Clinic and the Celiac Center, she is particularly focused on diagnosing and treating patients with genetic disorders such as hereditary gastrointestinal cancer syndromes and celiac dicancer syndromes and celiac disease.

Based on early results, the National Cancer Center Network recommended in November the testing of all metastatic colorectal cancer patients for the genetic dCancer Center Network recommended in November the testing of all metastatic colorectal cancer patients for the genetic dcancer patients for the genetic defect.

6/16/2008 UC San Diego Hyperbaric Medicine Team Contributes to War on Cancer Leadership Role in Nationwide Study on «Late Effect» Wounds The University of California, San Diego Medical Center's Hyperbaric Medicine Center is part of a nationwide effort to compile and evaluate data in order to validate whether cancer patients... MCancer Leadership Role in Nationwide Study on «Late Effect» Wounds The University of California, San Diego Medical Center's Hyperbaric Medicine Center is part of a nationwide effort to compile and evaluate data in order to validate whether cancer patients... Mcancer patients... More...

The facility, which will be located at the Sibley Memorial Hospital on the Kimmel Cancer Center's National Capital Region campus, is scheduled for completion in 2019 and will include space and staff for treating pediatric patients.

At the Harold C. Simmons Comprehensive Cancer Center, our support services for head and neck cancer focus on rehabilitation, survivorship, and psychology to help patients and their families through the cancer joCancer Center, our support services for head and neck cancer focus on rehabilitation, survivorship, and psychology to help patients and their families through the cancer jocancer focus on rehabilitation, survivorship, and psychology to help patients and their families through the cancer jocancer journey.

We offer a full spectrum of treatment services on site, including chemotherapy and radiation therapy, pre - and post transplant care for blood and bone marrow stem cell transplantation, as well as cancer screenings and supportive care services such as patient support groups and a cancer resource center.

IASLC would like to thank the patient advocacy organizations that have collaborated on this initiative: American Lung Association's LUNG FORCE, The Bonnie J. Addario Lung Cancer Foundation, Caring Ambassadors, Free ME From Lung Cancer, Free to Breathe, Global Resource for Advancing Cancer Education (GRACE), Live Lung, Lung Cancer Alliance, Lung Cancer Europe, Lung Cancer Foundation of America, Lung Cancer Initiative of North Carolina, Lung Cancer Research Foundation, Lungevity, Patient Power, Rexanna's Foundation, University of Colorado Cancer Center, Upstage Lung Cancer, Women Against Lung Cancer in Europe (patient advocacy organizations that have collaborated on this initiative: American Lung Association's LUNG FORCE, The Bonnie J. Addario Lung Cancer Foundation, Caring Ambassadors, Free ME From Lung Cancer, Free to Breathe, Global Resource for Advancing Cancer Education (GRACE), Live Lung, Lung Cancer Alliance, Lung Cancer Europe, Lung Cancer Foundation of America, Lung Cancer Initiative of North Carolina, Lung Cancer Research Foundation, Lungevity, Patient Power, Rexanna's Foundation, University of Colorado Cancer Center, Upstage Lung Cancer, Women Against Lung Cancer in Europe (Patient Power, Rexanna's Foundation, University of Colorado Cancer Center, Upstage Lung Cancer, Women Against Lung Cancer in Europe (WALCE).

The rapidly evolving field is centered on utilizing a patient's own immune system to surveil, target, and eliminate cancer cells.

Arturo Lopez Perez Foundation (Fundación Arturo López Pérez) is a non-profit center fully dedicated to diagnosing, treating, researching and teaching on cancer and delivers integral care to Chilean and Latin American patients.

As a physician / scientist I both run a basic research laboratory focused on breast cancer biology and see patients in the Stacy Goldstein Breast Cancer Ccancer biology and see patients in the Stacy Goldstein Breast Cancer CCancer Center.

An international team led by researchers at the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health and Fred Hutchinson Cancer Research Center uncovered the influence of genetic variation on vaccine effectiveness after applying cutting - edge DNA sequencing technology to almost 5,000 patient blood samples.

To evaluate the impact of ED - initiated palliative care consultation on QOL, depression, health care utilization, and survival in patients with advanced cancer, we conducted a patient - level, single center, single - blind pilot RCT of 136 participants.